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Reeoc-1 tic. of Reul Jbrperte1l810n

Renal hJperteuion, h1&b blood pressun origiDatiDg f'ro. a daaged
reaulatorJ apparatus 1.D the ll4De7, 1s a trequentl,y though BOt

De~l8arU.y

bereditary diseaae stfii.et1D.g about three per cent of the popula.tion ot the

Ull1ted States. l

In hypertendon, s_ll eap1llaries UDder tbe atra1J1 of abnor-

_lly aD4 cona1.tently high blood pressure are susceptible to brea.kace aDd!, if'

not

~d1atel.y,

death f'rQ.

hemrr~e

occurs vbeD. a circulatiDa blooct clot

tro. the repair of earlier .mrrhacebloc:ks tiDY capillaries) often

1.11

the

braiD or heart c&us1D8 oxyaen starYat10n to that organ or fatal heJIIOrrh8ee.

Rich blood preseure a ..ociated nth toXaia of preeDallCy is aDOtber 1utance of
a secoD4eLry effect of' UDSuspectecl real b;yperteDs10n.

At this

t~,

renal

byperteDslon correction, SUlit1cally possible in five per ~Ilt of all cases, 2 is

either

se'Yere~

1IIpoae1ble.

Itmtec1 by the Ice.rc1ty ot ut1byperteJl8ive d1'uc8 or 1s

el1D.ical data collected early iD the D.1D.eteenth century by BRIGllf, 3

au 1:D&1ish pby.s1c1an, re1tArated
~118101l.

&n

bypothes18

a.80c1at~

'This hypothea18 dates fro_ 200 B.C.

k14Dey di.ease vltb

lot until the last years of

the nineteenth ceDtur,y, bovev.r, vas the first successful research done on the

relationship betveeli kidney disease and. hypertension.

In

1.898

'lIGBI'lS'fiDt aD4

BBRmWIlI4 reported. a sal1De ..extract8ble "pres-.or substance'" fro. rabbit lrldne78
which they Dbed ~eniD· (t'ro. the IatiJl !!! for kidDey).

Experu.atal lJIduetioll of Beal Hypertension

•

The cl18covery of reDiD in the kidney luge.ted to their conteJlporary

sc1enti8ts that hypertell$ioD. could be 1Dduced ill a tesj; aDial by a defect 1.l1
the

DO~l

operation of the kidney.

The fust 8uccessf'ul. alteration of the

2
k1dAey which produced persist.ent hypertens10ll vas the

eO~8trictloll of

arter1.al branches, red.uc:1.D& renal arterial C1rc\llatwn. 5

renal

In 1934, exper:1m8nt1Dg

UDder hi. hypothesi. that renal 1sebell1a is sufficient to cauae byperteDsion

throug.h a MchaDisa

11r~01v1Dg a

b,ypertenslon in test an1:Mls.

a 1'_1 artery with

B.

6 achieved persistent

renal 8.cretioll, GOLDBLAT'r

aoU>BLAft'S teclm1q\le vas to constnct partially

silftr cta..p, leaT1D& renal arterial branch.s Wlto\lcbe4,

thereby creat1Dg renal 1ac))ellia.

tn the test e.D.1.-1.

Subsequent persistent hypertension developed

To reveree th1. expe-l'ael1tal

~rten-'1on,

the ClalllP vas

remved, .allov1.Dg
. llOnBl blood flov to be restored aDd to relieve .i.chall1a.

GOLDBLATr observed that peranent byperteu10n 1s 1D4uced by pertial CO.D&tr1ct10n
of both arteries.

GftJW.lu celIe in tbe Juxta&lo_rular apparatus (Jca) a~ in the valls of

adreDocortical arterioles
were discovered by JdJI'tBR7 in . 1925 8Dd bave been the
- .
subject ot succesa1Te postulates.

In 1939, aDd ap.in 1D

1945, OOOlIIA.GJft'IG~ ... lO

alcribed an bormDe-secret1Dl relat1oub1p ot these lraD\llar Jaxtaclo_rular
(JG) celli

:to ~ten&1on.

location ot
role.
dl"UC I

In 1941 DtJINIIIDB

11

emphasized the a4reDOcortical

80_

of' tbese cells aDd studied the cella tar a po.sj.ble adrenocortical
12
_
GARBD, et &1.,
111 1959 studied the ettecta of iDduce4 ~telU1oD md
~-

OD

the fP'Uular JG cells poatulat1D& that tbt JGA

ac1reDocort1eotrop1c hormDe (ACTI).
~.. l.Dcluced eff'eeta.

~B S

target orpD tor

Otber laboratories vere unable to obBerve

By 1960 the 1Dd1v1dual granules 1J:l

JO cella bl.d been sbovn to contain all kidDe)' renin.

t~

CytOplaSlll of' the

Dec'TU8eSand increases

in JG cell g~la~10n and nUllber with acnase Qd 4eCr~&8e of. ~l arterial

pres.ure, respectively, bad been observed.

In the f'ollov1Dg year 'roBIAll 1 3

3
Buagest.e4 that 1D.creased granulation represented activation of the renin in
the granules, aDd 1.Dh1b1tlon ot Doral pressure controls, by a deereaH in

6

blood pre8sure (contrast OOIJ)BLATT" ) •

. 14

PAGE

had foreseen the 1JIportance of

In later experiments 'l'OBl.AIi 1 5

renal arterial preseure twenty years ear11er.
supported his pftS8ure influeDee

postulat-~

by smv1..D& that lover1ng renal

arterial blood. pressure devates the rate 'of -reJi1n seeret1oD. in the JGA J that a
sU1HJequeJ1t 1D.crease in the arterial blood! pressure decreases the rate of reniD
seereatioll f'urttenore, constriction ot the arterioles increases the rate of
reDiD secretion.

lie was un.able to fiDd oonclua1ve evid.ellce that a

!barR

1.Dcrease in renal arterial pressure lovers the rate 01: renin secretion.
theee later experUleDts mBIAB also observed
the amunt of pla_ renin aDd racllcal,

lUI.

iDve:ne

presWBb~

In

re1ationsh1~ between

,causal chaDges 1D blood

volUJle, indicating the po Bslblli ty of extra-:re-l oontro1 Crt' rel11A secretion.
'fo mter GOLDBLATT'S theory of the 1Jm)lvellent 1D elevated blood

vol~

(rmd

theretore in rena 8ecretion) ot iacbeaia tro. mBUlI'S,. an4 not, GOLDBLAft IS...

b'lood volume cba;Qge experu.ents. .AD 1JIverse relationship betweeDi _rked
BodlU1l-1on (JIa t ) Q.epletlon (8.M 1DtIKe) 8D4 plasa ren1n levels '81tilar to the
bloQd volu. Cd plas_

reum level relationship "*8 reported:

in the

sa. paper.

This lIa. effect is pos81bQ' due to an menaae in tluid retention with anU1erease

1D bod;y Ra+ level (aa.4!!.=! versa) and. thus _y be UD4entoocl 111 ten.a or the
volu. effect.

However, the JGA _y be capable of directly' de:tectiDg lfa t levels.

TWo types of cells are toUDd 1D the JGA:
JG cells.

m~

the . .cula deDSa cells and the granu1.&r

P08tUlates that -.eula c1eu8 cella contaiD reniD in a precursor

fora ·and that the granules in the Cytopladl of the JG cells secrete tbe active
renm wben. EcUla a:eDsa cells are tall, BIl'4 ~ in en<1ogrDOus eJiZjlles other
tlan renin (ef. Leyssac

16

>,

Tb1s integrated fUl1ctlon b~tveeD the _Cllla densa

cell. aDd the ll'$Jlular cells is 1Dterred from data shoving "liD ret1lular fibers

4
aepuatac the 'two type, or JGA. cells.

Vbether

So

case of b;ypertell8ioD i8 of

renal ori&in call be 4etenl1Ded 4utl:ag 8uraery by JQA bioPsies 17 vh1ch shoY

depletion aDd bypograDUlar1ty of the ll'Uular cella with l"eDill bJperteDslon.

LBrSSAC 16 reports the 1ntr&ftDal coUPliDl 0:/ reabsorption ot the _jor
traction ot 8Od1ua chloricle (BeCl) and vater to JG tiltration to be nc-late4. by

an 1Jltrarenal aecbar:Usa.

111. ezper1Jlentl iad1eate that the 11berat1oD of rell1J1

i . 81&Uled by a decreaee in tubular pN8SU1"e 4ue to 4.ecrNse in laCl CODCeDtration.

A:Dcioten.1J:l, a px:.-s80r peptide nleasee! fro. the c1rculatiDg ren1ll. ~ub8trate by the
liberated rena adjusts the tubular reabaorpt1ve capacity.. thereby re.toriD&
noral tubular pressure (and thus caus1na resto:tatloD ot DO~l JG t1ltratlon

rate) •

LBlS8AC ~tbedzes that this -alo_rulotubul.ar baaDee" 1Dvolve. a salt
eonaenat1Te feedback _cbaDiaa 1n which

aD

UDk:Iiovn 5-1pal, po.libly th. release

of • bonone, (aldosterone), 18 a.lerted by ftriat101l8 1D aeula d.ensa cell salt

cODCentratiOIl,

C8USlDl

secretion ot reniD, which, tbrouah the glo_ru\otubular

bal..Qee _claDi. ., eventuall,y return salt concentration to oorma1.

********************
THE RDDI-ANGIO'lWISII SIS"1'BM

AD&1oten8iJl 18 a key peptide twletiona& U the ren1n-&ng10t4;IL81D
.ecbanim ot " __ 1 blood pre.sure reculatioD,
.

-

81

_e1aDisa which bas been revealed
.



aDd inereaa1Dgly substantiated over the last thirty years.
the anciotells1D-renin systelll involves the

&CtioD

Rough!y eu--.r1.zed,

on the leuc1De-1eu.e1ne

5
(L-Leu-L-Leu) bond in the renin substrate (a glycoprotein) by the el1Z)'lle renin
to !'alea.e the deeapept1cle, ua1otel181D I (probably an '1.ndU'eet pre8sor).

A

chlor.1cle-ion - requ1r1;Dg convert1D& el:lZY1lle llberates the octapeptide anaioteu1n
Tbe destructive action of aDC10teg: ..

II, a powerful pres sol" , from 8D&ioteJ1linL
liDasel on aD&10·ten8in

.111

19lfo

two

!!

~.

i& probably of IliDor extent •

I~t re.e&~b l1"Oups,

PAGB &D4 RI!Uf£R (U.S.) 18 e.nd

BliAtII-lmlBlDB (Aqent1Da) 19 arriv:ed at the first h1.At ot the rea1n-ugioteuiD
lleCbu11ua by abow1Dc that in • re&ction between renin $nd a renin activator
(reniD IUbstrate) a cryst&111De preuor peptide (&D&loteDs1n) is released.
subatrate, a proteIn 1D tbe a lptB 2 -&lobul1.n fract10n of plaSJB,
three year. later by PLIB'l'L, PAGB &Del DAVIS. 20
attrl'bute4

~

.11~S

The,e

de.cribed

In 1946 BRAUJI ~1IQ)1Z21

vitro destruction of anciotells1D to

cells, and otber hlm!t.n tiS8ueS.

va.

Benin

e~.

in pas., red:blo04

Mve aince been found in m'st

body t1s,~e aM are predom.1..Dant1)t 0''1 one type, giveD the D&IIe 1t.Ana:1oteI181Daae A"',
~

by IlIAUIALLAB, BUMPUS, PAGE, aDd SMlBY.

etby1ene41aa1Mtetraacetate(:mrA.)', C.

pH OIl all l'orms of aDg10teD.s1n.

22"

.

Anilotel181Dase A 1s dialyzable agaUet

2

.! r.fh·~ o,pti_lly

active at

p~s101o&1ee.l

Vhether An.g1ote1l81Daae A 18 e:t&n1t1cantly active

111 vivo 11 uncertain beeauae 111 vitro experiJlente tor

purpo&eB

of

8SI&,.

use

concentratioll8' of &Dglotens1n Deh in exces8 of conc.en.t1"e!tionB existing ilL vivo.

-

The

re_1D.~ &Da1o·tel18~sea

-~

difter fro_ ADg1Qten.s1naae A in tbeir 1Dh1b1tlon

by d1:l8oproWltluorophoapbate (DI'P).

Aeeor41_ to. stu41ea by BUMPUS;3 the actioll

by aD&1oteD.a1~Ses loeate4 111 tbe walls of blood yes.ela -.y be physiologically
-

-

significant a:tter the disappearance of pre·s·aor ",ponee ot re_1.n1Jr& pas_
&as10teIlJ1n.

Circulat1D8 a:agioten81D.
II -.y be aonex1st4nt if, . 8.S
.

the rea:1l1 and CODVert1ng

veasela.

eI1z:y11e

~4

notes,

are locatBd near (o,r iAe1de) the valla ot blood

6
III his ear17 work on tbe rea1n-&Dg10tens1n mecban1S11, SlBJGS25 found. 111

circulating-blood assays' fro. -.ligDant byperteDslve patients, cOlIIpe.ratively high

levels 01" 8D&iOte11s1n (went,. t1Jles the noral) and ren1n, evidence supportaa a
role

ot reni11 1n the blood pressure re&Ulatioll mec:hania. o'! hUlBn hypertensives.

A 1969 report

26 cited

tbe dlf't1culty 1.11 JDeaBUl'Ulellt of circulatiDa ren1n activity

t_t remval ot blood, se..ples neeesAry- for atan4ard assay creates
depletion that pbysiological l'eapoD.£eS occur, thu.t
latiDg rellin.

111c~a.1D&

a volume

NIOUDts ot circu

'lh:1.a difficulty -.y expl&1Jl excesli". eirculatlq

us1oteu1n) levela found by SUGGS.

~uch

~1l1a

(aDd

1'be report iD.e1u4ed an 1aproYe4 circulating

reDiD. aaaay aDd used tbis &s8&y to d,emD.Btrate an 1Dere.....e in circulat1.D&-ren:1n
actiVity 111 rats Nsult1Dg tro. vol\Qle depletloD.

~

which acree vith mBIAB fa 15 reaults SAd b;ypotbesls.

80diua depletioD., 1"1""'.s
In 1954 by s1Jlple acid

deuturatioD. BAAB, UMFlaI, &J)4 GOJJ)lUA'r!'2'7 110 late<1 renin, an ellz;Ae they ba.d

described as very tbermlabile,

~

in a partul.ly purified, fOB.

ill the sa.- year puritied ansiotene1D I fro. horae plaSIlB.
GRUII

30

SIOIlGS;I.!! al,

~

111 the 1"011ov1ng year

devised a _tb3d tor pe.rtlal pur1.fleation 01" bog-plasE, relL1n Bubstrate

by amml11ua aulfate fractiooa,t1oJU p:reced1D& and 'to,llow1ng partial acid denatur

ation.

SlCBDGS31-32, and ILLIOT and PMRr 33-34 determined the all1Do .c1d

sequence ~f aDg10tens1n II and by 1956 fIC.BJGS, et ~1,35 we~ able to 411cover
aJa4, mderate'17 purify by fraetioDal &.->niua aullate and iaoelectrie precipitations

tro. horse pas_ the

ct-.

aetivated COlNertiDg e~ _' St\Jd1 01" the reaction

Mdie.ted b)' this t:nzyae (conversion of qgloteA81n I to angiotel1JJ !D II) aDd of
the an11&ble lmowle4ce of otber cOllPOnents of the renin-angioteDs1D sy8tell
thus reTealed the first 1D.tearated .chaDlsa explanation of the ren!n-aD&1otens1D
sya~..

...

~iotens1D ~

aDd not aaa10tenain I was shown to be a powerful pre880r.

AD&1otena1D 1, the product of the reD.in substrate b,ydroqe!s by ren1D.,3

6

rate..detena1n1na step 01" the mecban1sa, 1s DOt directly vasoconstrictive.

111 the

7
Circul ting Blood:
Pressure normal

Circula.ting Blood:
Pressure decrease

Circulating Blood:

Voltnne increase

KIDNEY:

Reabsorption
of sodium-ions

Renin activity destroyed
by renin inhibitors

~C>~culat1ngBloo~
Renin substrate
(f'rom the Ii ver)

Release of Angiotensih I

Release of Aldosterone

Circulating Blood:
Converting enzyme

Release of Angiotensin II

o
c

o

Angiotensin II activity destroyed
by angiotensinases

FIGURE I:

CAL CO DITTO S Al D REACTIONS INV LVED I
- IOrrENSI SYSm

r THE

8
Figure I shows the biochell1.eal conditions and reactions of the re111n

aDCioteDe1n 8Ystea as accept~d in 1967.

SllI:iG IS clarification ot tlle renln-anaiotens1n system

through, yet

OB~

UDVeU.1ng of the
-

YAS

a mjor break

a ataniDe po1.Dt for the goal, still DOt reached, of complet.e

ECban18118

ot the system.

partial purification ot borM ..relrln
ot borse-rctlWl wbstrate.

By 1957 .1Jl 5KBJG'S labOrator;rr7
-

subBtra~

'l'he structure

had led to a tr:JllPs1D c1egradatioD

ot th!l resultant substrate polypeptide

tra,;aent vas detenained to be that o,'f 8Dgiotena1D. I plus tour a.;1no acids.

Figure

11 &hows the c:2IIical structure of trypsiD-4.eC'ade4 horse plas-. reDiD substrate,
relative to the structure. ot &l)gioteuiD. I aDd
.
tbt structure 4e.tenanat10D, t3Psi,D, vh1c:h
only to the (conventional) right ot basic:

~1otensiD



noraU, breaks

II.
8

Accord1.n& to

polypeptide cMiD.

.amDO aeids I 38 16 al1~ed

brokell tbe ebain totbe right ot 4er1.Da I an

~roxy-aJliDO

acid.

to have

Thi.a curious

polypcJpticle into aqiotensin I 1nd1cate4 the sufficiency of the pol,yP,ept1de
6.

81!1

renin subs.trate and pointed to a possible chemeal assay for renin to, replace the

SlCBDGS rat aesay.J9

lfhe polfi>eptlde substrate was syntbeslzed40 aDd the reD..1n

vas shown to·
bnak. the L-Leu-L-Leu bond of ·the po lypept1de
substrate.
..
..


In an

'

enre_ly cs1.ow

~

vitro reac'tioD J ang1otens1..D. II va. broken bY' reDiD into tvo

tetrapeptide.
"hieb inh1b:L.ted.. ren:1.D in the absence of 'erwa.
-

~10tena1Mse

Serwa vithout

act1vit7 reducced, the inhibitory effect on renin,41 iDAUcat1D&

the rrobab1# UDillpOrtance 01 this slow reaction in vivoj

•
A.Qg1oteDsin I pept1des vith isoleucine (Ile) :in the fifth &JI1.DO acid pOs1.t1on
vere (; isolated fro. borse aDd. bog pas... and shoW to be identical in corroborat1Dg
.-

pur:U"icat1ons)6 J 42-47

-

Bovever bovine-phs_ aagiotensin I (and n) differs '1'ro.

~he gl'yc.orI"'Qtein

so.

9

i.1"''yps i n- - - - - - - - - - - 

VAL

LEO

Li.U

HIS

convel"tin g en t.j"'~
Clw

HIS

lLE

VAl.

ARe

10
horse- aDd ma..plaam augiotensin I (and II) by the presence of valine (Val)
in tbe fifth aa1DO a.cid pos1ton.

48

Horse and hog angiotensin II synthesized by

SCarARl'Z, BtlCPUS aIl4 PAGE',49 and. by SCBIYZER5 0 in 1957 proved to be partially
raee.bed.

}Pully

actl~e

18oleuc1ne.. 5 angiotensin II vas synthesized 1n 1961

by AlWCAWA and BUMPUS. 51

Bm ine aDglotensiD. II (valine -5) va B synthe sized in

.
52
1958 vith no raceBl1at1oQ difficulties.

Figure III shovs the cbelt1cal structure

of t:ryp81n-4ep-aded poviDe reniD ,substrate and 'bovine ana1otens1n I and

augioteu1n 11.
teD'~

Intr&40rtal injections of both fonas of. the purified ana10

I produced pressor effects OD 1'8.'bblt b 1004

preuure equivaleut

o't purit1ed ang10tens1U II inJectiQns, 53 which is evidenee, aceord1Dg

to tbose

to SlODGS,

for fast convertlng-enZ)'W! actiOD on 8Dglotens1D I, the probably biologically

1Daettve form, in the reactlonto aaglotensin II, the potent pressor.

tor biological activity of angiotensin bave been studied

by

Requ1remeDts

BUMPUS54 and SK!GG&55

1n an effort to understand tbe RCbani8JI of renin action on its substrate and
thereby to develop asyutbetic substrate suitable for an . autoll1za1;l1e
chemical

assay

ot reDin. fIO!DGS55 has

l'el:eDt'l3

synthesized 1l1ne such suitable peptide

suilstrates aDd U81D& a pre11Jl1oary cbea1eal assay bas stucUed. the .erits of
the nlat,ive kiDetics of each ren1D-substrate systea.
BUiaested: for use in chell1cal assays for ren1h ill
F'j,gnre IV.

'!be two sUbstrate'

~ ' ~port a:r;e

SboVD in

Serine-U•. Me little effect 011 the Micbaelis constant or -.n..l

velocity, however the h1stld1De-Ur1dazo1.e group 1D 8JI1Do' acid pC>sit:1on six,
prol1De· in position seven, tM phe~l side group on, pbe~ in .position

e'1g)rt, &n4 a free carboxyl

~u.,p

on the C-ter1l1nus ai"e absolute requirements

for the ren1D substrate. \In add1t1Qn the substrate mat be at leaa.t six amino
acids 1D. 1.e'ngth.

A clarification of the biochemical relationsMp between hypertension and

VAL

re nlll - - - - - - - - : x L~V

HIS

HIS

VAL

Vftl

SER
1'fR

YAL

It..U
LE.U
HIS

'PH£.

HIS

HlSI. to S£.R
_ IGURE IV:
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elevated aldosterone levels vas accidentally toUDd by LABAGH56 and BIROJI 57 in

1960-61 dur1 DC an inveat1ption ot pta. . reIl1n subltrate level regulation.

LA.IWJH and BID both sbowed aDiiotos1n II to 8t:t.llate adre-.l aldosterone
-

-

secretion, but vbetber tbe amunt ot

bo~ne

secreted vas suft1c1eAt to reeulate

pIasa ren1D substrate at a con8tant leYel was DOt deteDl1ned.
Renin substrate, iD further 8tudies, bas been identified as a

s~prote1ll

present in the alpha 2 -globul1n, and poss1bly beta-alobul1n, hactiOD8 of
a~

Altho~h

1n circulating lywph.

pal. 58

reJ11D substrate 18 tholllht to or1i1Date in

the liver" 'DO evidence bas been founa for the pl"e8ence of the 6ubstrate in this

orpn.

59

In 1954 SDlJGS

60

reported purification tra.

of reJ11n substrate (calle~ A, Bl, B2, el, C2).

boa

plasa of five foras

Two aiDOr fo1'1l& D &Ad B

recOYered during purification in in.ufficient a.DUDt. to

puri~

were

satisfactorily.

SIlIJGS md1tied the claulcal boa rell1n substrate purificatIon :.ethod 01' GBDR
aDd BUMPUS30 with batch (tractionatIon) and eollDlD cl1,etb;y1.all1uoetb;yl cellulose
-

.

.

_.

(DKAB-ce11uose) cbro_toarapby I 11quid",Uqutd partltioDiJla, aDd countercurrent
-.

-

...

distribution of renin substrate aDd. serumproteiDa in aqueous glycol aolutlol18.

61

Ultra centrlf'u&ation follow1D1 th1a m41fieatlon of reniD substrate purification

revealed all five foru of' substrate to bave e.pprox1ately the sa. mlecular
we1aht, reported as 57 000 in two reports 55 ,62, aDd probably ftported in error

8'

58

000 111 8Dotbe.r. 63 A:a1no, acid e01llpodtl.ona

ot the five glycoproteins

were DearQ' i4.ent.lcal, but carbobydrate portioDs provided tbe 41:ffereDCes

1a

~11cal

convert1D4K

properties.

en~

11 sub.trates upon

~.ct1on

with renin and activated

liberated a."tical ana10tena:1Jl II mleculel., Reaction of

these substrates v1th trypsin yielded the tbermatabl1e, dialyzable. pol)'peptlde
identical to tbBt derived fro. tryps1D deCradatiOD of Datlrilly-occurnnc horse
aDd

bee rena substrate. Bates of lwdrolys1s by reDiD on all five substrates

yere close, except 111 the cases of the two lea at purified ii ub stratea, B1 sa d B2 •

Tbe enqJle renin • • been the mat elualve OOJlPODeDt of the renin

&lJCioteu1D. 8Tste..
_rular cella 1

&1

Althouah reiJI. i. localized in the cnmular .1uxtaglo

_ntioned above I the

occastoully in other Orgus.
have

64

e1lzylle

is foUDd in arteries and

Conaeque.tly ettorts to puri1'y the

becun nth treat.nt of the k14D.ey.

~J1blJl

e~

-

sulfate fractionations,

DId-chro_tosraplv",66 and trietbylaa1noetbyl (BU)

65

chro_to~pby65 of crude

kidDey reD.1n preparatiolls bave produced; 01117 partially purified rain.

MBa"

LAMPB(Jj I an4 OOLDBLA1'T 28 have •• tab lished the ..pecif'ic actiV1 ty' of' pure reD.1n
at

780

OOLDBLA!r'fOn:1t. per..

ODe GOLDBLAT!' UD1t is the activity of a renin

SUlPle equivaleut to the aet1v1.ty of 0.45 11K pure aqioteas1DII.

baye

reeent~

T1."O croups

derived relatively pure renin fro. kidney preparations by mdi

tlcat10n of previously used tecbn1quea.

MUD and II"BJA1I 67 used TIAI-eellulose

purification (See also II)IGAJr and LmJI6 5), cuani41Doetbyl (GE-) cellulo.. ,

-'1_ s.pba4e)C with tour-told vol. . reduetion,u4 dialysis acaiut i"ris-aal1ne
butt'er.

fKBJGS66, usiq a DBiU-eellulose pB gradient, eluted four tOl'WB ot

ren1D, whoae difference
the

~

1Dvolve only spacial eonf'1,auratiol1 alterations in

clue to carrier proteiD etteet

_~

OD

ren1D.

The spIlcial coD1"1gu.ratiOl1

aDd tbul the _cDm1.s. of' the reniD-renin substrate reaction have DOt been

elucidated.

Renin, due to its thel'B)bability aDd the l.&rae

loiS

of' activity en

coUlltered 1n purification, baa presented the lara_st obstacle in renal t(rpertensi011

rese&l"ch.

With the kDovledce ot ren:lJ1 conftauration and Ecbanisa such problems

as the :renin auay, eadmua-lon (Cd2 +) and z1De-ion (zn 2+) (and poas1bly other
divalent cations) ef'f'eets, ud inhibitor studiea could. be more efficiently
attacked.

•
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ASSAYS FOR Bi6DI

Despite the diffieulties encountered. in renin pur1f1cation,&saay of renlD
cOlltent 1ss1mpler
thaD. assay 01
.

aD&10tell~Ut.-coDtent.

Use 0'1
. renlll presence 1n

arteries bu bee _de in pla. . assays of :reIl1n68 in which a crude preparation
of reD1n t"ro1I treated plasa 1s perm1tted to react w1th renlll substrate and the

ren1n 1s tbeD assayed 1ndlreetly by activity aasure_nt of the reaction resultant
1Jl the rat.

The rat .uay used in the Colby College labo:ratQry I

a.

a ,direct

'6

aesay of 1njeeted.-X"8'n:1n activity I 1s &ID41fied s:mGS rat assay -, in which an
anae,thet;bed rat 18 injected intravenously with a ren1D preparation aDd the

resultant cbmge in blood pressure is measured with a aBometer CODJlected by a.
CAllllula to tbe r1&ht carotid artery of the rat.

The assay 1s delicate I 1eDgt.by,

aDd accurate OD4' to ~-l~. A chea1cal assay of renin va6 developed. ill the
sa. laboratory at Colby Colleae by KcDaIIALD (1968)) however as his assay 1s nearly as
,

a.rduous as the rat aS88Y, all further work in the laboratory has been perfora4
udng the rat assay.

stemGS 55 has partiall:.1 developed
a cheJl1cal
assay of reniD
.
.

by 8yDtbeai8 of peptide. vulnerable as sub'trates to action by renin however

naltber b1& prel:ll11D8ry chemical
luitable tor

\18.

&8IIay

nor his partially-developed assays are

at this t1llle.

CAllOUt lOlf AND ZIBC lOB Bt),Jt'l·

The roles

ot Cd2t aDd zn2t 111 nnal byperteD.B1ou were observed

SC'lIJOEBR~~:!t.. only

recently.

NaDy

by

ot hi. obeervations are froll. _controlled

cliD1cal aDd autopsy 1ntoration" bovever he baa conducted three notevorthy

labora,tory experiments.

In

aD

experiment reported in 1962 9:BR)EDBR72 obse1"'1ed

oral Ca.2+-1Dduced hypertension 111 youua f.-le rats.

In work with 'both &eXeB,

16
feale. teD.ded to develop

~rteJl&10Dl lOre

retUrDed to _le6 later in their Uves. 73

ofts tban ales, however ~rt.J1Blon .

9::1R)mlBR a880ciated shortened 11.:fe

span with hypertell&iOD &Ad auagelted that the aDt1Mtabol1te role ot cadmiUli in

the 1d.4Dey vas due to

8.J1

1nc~8e 1.11 the reM1 Cd 2t _ZD2 + ratio.

Belatl••

deficiency 1A renal z1.J1c be 8&1'674 1. theretore po8sibly responsible tor e ... D

tial bn»erten8ion.

IlltraveDOU8 aDd 1Dtraper1tou.e__l inJections of Cd 2 + also

produced bypertensioll 1D rats. 75

In

* third Cd2t- hypertension

exper1Jlent, a

zinc chelate bav1Jli; hieher stabil1ty as a ca4a1U1l chelate (UDCO~76) was
lD,jected into Cd

2+

-induced byperteABlva n..ts .17

preeaure va. 1Dterpreted .e

So

reversal of hypertell8loU.

Cd~+ _ZI12t

the loveriDs of bypertell810n-elevated

bypertenaion reverlal.

Subsequent loweriDs of bloo<l

ZiDC 18

art essential

cada1\D1 i . probably DOt eueatial. 10

fl:HR)JI)BR pouted to

ratios a8 the .ecauu. . ot

trace ele.ut in DlEUllE1I

78

vh1le

In tact, 111 the _ _ luu JUcme,. cadaiUli

is a cUEllative poison. 79

Table I shovs zinc aDd cadlliWl levels e.D4 toxicities .1n -.n.

Both &1.nc aDd

82
cu.1ua !'Uk &s very h1ah potentials for plllution
aJld, 1D view at their

toxloit;y to

laD,

add prospects of' death or 1D.4uced bypertension to PQllu'tion.

Polluted air contains 0.2-2 JI({j.3 z1llc
t10u, vill kill a l50-pound

_ll

83 which, t'ollowiDtl approxiate calcula
..s.

should be breatbtt'roa 35 to 350 .e·terpof it.

81,84

1'bat luch a pbellOlleDOn is even conceivable 18 alaraiug •

2

.A.ccord1Dc to fl:JIEI)II)BR, Cd

the k1dDey.7

0

IAGI aDd

V~85

+ 11

boUD4 to tbe prote1J1 _tallotbtODe1l1 111

report

ODe

.olecule of atalloth1one111 fro.

horse k14Dey to bind nearly irreversibly three z1D.c atou 5.Dd five cada1.ua ato...
1'be introduction<) 01' exceS8 cacbd.ua to the k.1d1leyvill not cauee -.tallothione1D

'to ).o8e zinc atolLS de,pite the greater e1eetronqat1vity of cs.daiua. 76

SUa1larq
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sc

ON

an _'issues:
130

• m•

6.7 'P.p.m.

Liver

t

~~. ()

ers

130 p.p.m.

trace only

13-180 p.p.rn.

Intraveno s

'.i hly toxic

.lloderately 'oxic

nject"on

(1-10 mg/
bod Hei ht
s let al)

Toxici ty to

an:
(10-100 mg/~

bod
eight
is lethal)

Oral Ingestion

31i htly toxic
(100-1000 mg/kg

bo
-'Ol:ici ty to .. a.t s:

Oral I

TAB·

estion

I:

Cd~

Toxic

0.5 g/da

D Z~ Levels in

Lethal
16 g/da

eight is lethal)
oxic

50 G/da

Lethal
150 g/da

.Y
df1iati Tis~ue~D and
•
Tox. c:lt.".es in :an . and ats tl1

1
introduction of a zinc chelate will not liberate

CS4JliUll

f'rom metalloth1one1n

despite the ITMter st&biUt'.f ot a ea4Jl1U11 chelate tban a zinc chelate.
8':JIB)IDIR71 DOtes tbat eXMas c.4a1ua produces b,ypertU81on in rats aDd mce,
but, he tailed to

st~

the. effect ot Dceu zlllc alane.

foUDd that both Cd2 • aDd ZIl

:rro. bovine

.ample prepared

a+

JCAImt,~

a1. ~6

1DdA!peD4ently act1Yate a trlce-d1alyzed rell1.D

kidDeY'.

Purther, wben the cations vere chelated and

rBOYed by a third dialysis, reDin actiY1ty

facilitated remval of a d1aly!able
activation ot rellin.

III 1969

re.nm

~1DM

elented, sugestiag cat.ioJU.c

iDh1b1tor ratber thaD d1rtct cationic

Dialysis of the crude ren1D. preparation all&.1ut Tris-aa11Jle

buffer (ZD t2 aDd. Cd t2_free ) also increases ren1D actiVity without relK)val of

67 86 Piaure V shovs

contamDanta.'

the eftects of the dialyses aDd eat101l8 on

reniD activity.

All "antireD1D ~ eerua" vh1ch

Up:l1l

inJection lovers tJ» bloo4 pre.sure.

aod 1D.cnaa.a Juxta&lo_rular cell aranularity aDd reIl1n content baa been studied
1n the kidneys of dosa treated bY' GOLDBLA'rl' 's claJll)ed reua1 artery _tbod aince

1940. 87 InjectiOns of bo(l; renin in dogs produces a boa antiren1D which deactivates
QOLDBIAft-401 rq,m a11ow1D&

anilBl reniA 111

JII8Jl

DO~l

blood pres.ure to be restored.

InJections of

fa11a to produce DeutraUz1Da antibodies tor huan reDiD. 58

In 19620RBISOI87 achieved 1nh1bitioll ot renal b¥Perteneion

1~ ~Dkeys by

huan

&nt1relliD an4 e8t1Jated tbat 1_tn' zatiOD tro. real b;ypertens1on 1D ODe an

vou14 require antirenin fro. 250 000 II)Ueys.
reD1D. :found by BASS, GOL1mLAT'f and

G1PSOIf58-59

A partially acetylated bulan
:1D

L965 to produce antlbod.1es

aga1.Ut hua,n renin
is now the only '.u.ecelis:rul atte.,pt
to develop an antlbyper
..
.
tend.,.e drus, bovev'er the sc:arcity of available huan kidneys prevents widespread

19
use ot the drug.

Here 8&"111 enouah lcaowledae o:t the enzYBle rcm:1n to produce

IJDtbet1c rerUn would coQet1tqte a ajoX' breaktbrouch.

ot
tbe

:ren1D accord-.1Dc to smGS62 WOuld DOt
oc~pept1.de

8~SOrb ,on

PJIl) ...pg...IIIS ..LID-LlD-VAL-TtR-sER

boUAd to the active .1'te, of tbe

e~.

A 8ueceslf'u1 1nh1bltor

MrtIIi proteins,

!.! vivo,

a8 does

aDd vou14 be tiahtly

I11d1eatlon tbat tb.18 1nb1bltor 1.8 DOt.

an entiren1D 1" given by the UJ)eraent. of'MUIBBI'AD, JOIf:BS aal S'l'IlIIAI

88 on. the

DOraUz1llc effects ot a renal -.du118 ex·tract 011 the elevated blood pressure of
teat do&l; u4 ot PAGB,!!

pat1e~t8 as ear~ a8

.!!.. ~9

1941.

OD d:m:Uar ef'fects ot' k.1dDey extraeta on bu-.:n

MAlllB 67 attr1butes the dalys18 effect ot renin

actlvttJ' eIlhaDC• •nt (tn the ab8ence of remftl of iJlpurltles) to loe8 b1 c!lalyals ot

1..

Ob8enatloDs on Cd2 + a.Dl1 z.n2+ effects 8UB1arized 1.11 £1aUre,

ren1n 1Dh1bitQr.

V bave lead to the preeut u

e

w1Datlon ot

d1a~PD4s

rQOval bY' d1aly"u 1, f'acl11tate4 bY' C4.2 'or Zn2 +)

tor

q

1Dhibltor vmse

Recently SDI, 5MBBY aDd.

BlJalUS90 -9l partially ieolated! a reDiD 1D.h1bltor fro. can1De k1,4Dq.

Thi1s

1Db1bltor 1.. bell.evecl to be a pboepl:lcl1pld 81J1:l.lar to 'bovine pbospbatIdyl,er1De..

however the nature ot OM of the three side chains 1. UDkDovn.

IDhibition ot

ren1.D
in vivo aM. in vitro .Te beeA c!.eIDn&trated with this 1nh::tbitor.
~-~

T"'De _thDd u,ed by SIll"

BNBBY aDd BUMPUS to isolate a pbospml1pld ren1A

1Dh1b1tor 1DvolTes e,n acetone powder ot the k:1dDey,
two chlorotoJ'll-_tbaDol
.
.

extractlol18, 'a

~P~cl

precipitatio.l1, &I1d colua chro_toerapb;y• .It, as

by MUIR &D4. co-workers, the reIDval or

&!l

1nh1b1tor

~Y 4ia~Bis

bomcenate ~ facIlitated by the pres.ee ota44e4-cadJr1.ua
in the

1011s.

bomaeDate, the isolation ot the iQh1bItor(a) Deed DOt be
.



.u~pecte4

01' a kidDey

(~r
8Q

'Zi.DC

.ions).

fie41ous.

,We

propose4 to ~e8t~te theee ~8.Ull;ptiona further in ~. a~te~ to deIDutrate
the ex18tene.~, in Iteerkldneys, of an 1Dh1bltor 81.111:ilar ~ that repo~ed by

SIll, flllBJ, q4 BtIIPUS.

Ve t11"st 4ete:rm1ned to iDvest1pte cUalysanda

which bad eDhanced renin activity in earlier work.
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ot dialyses
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-
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PART II: EXPER

L
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MAoTERIALS AND MElli ODS :

Preliminary Details

Normal saline is 0.9% NaCl, biological grade, in deionized, then glass
distilled, water.

Tris-saline unless noted otherwise is 0.05 M Trizma

base, 0.9% NaCl, and buffered at pH 7.3 in deionized, distilled water.
Trls-2x saline is Tris-saline with a total of

1.8%

NaCl.

\f,perlensin IT (Anp,ote1sin II - 'Ciba, 2.50 mg in 100.0 ml. Tria-saline)
is used in O.2-ml injections (0.005 mg per injection) in t.he rat assay
a stand ani for units of renin activit.y.

8.B

Sodium aytal - Lilly (sterile

sodil..III. amobarbital, USP 0.5 g) is divided into ~-mg portions and taken up
in 1.25 ml nor.:na! s,aline when

neede~

This anaesthetic is injected

intraperitameally in the rat in a dose of 0.6 ml plus 0.1 ml per 40 g
boQy wdght oyer 200 g.

Atropine sulfate (Burroughs-Wellcome and Co.,

0.05 ~ in l-CC ampoules) is injected in doses of 0.5 ml per rat.

Sodium' heparin - Lilly (1000 USp/ee) is injected intravenously during
the operation prel.i.minary to the rat assay in 0.8-ml doses

(BOO DSP).

Young male rats of the SPRAGlE-D

freo Taconic Farms, Gemantollt\, New York.
peritonitis.

I

~r

rat

strain were purchased

This strain is resistent to

Steer lci.ctne:rs were donated by Aleo Packing Company, Winslat,

Maille, and were frozen soon after slaughter.

model number' HR-l was used at 15 000 rev./min.

A..n International centrifuge
A Beelonan Zeromatic pi

meter was used to make and periodically to check the Jilts of buffer-ed.
solutions.

Cacblim and zinc

cont~nts

of samples were analyz.ed with a

Perkin-Elmer Ko:1el 303 Atomic Abso!iPtion Spectrophotometer.

Dialyses

vere performed with Thomas Dialyzer Tubing No. 4465-A2, inflated - diameter

5/8 i,nch.

23
One worker has questioned the value of the use 11 rats in renal
hypertension research, alleging hypertension in rats to be different from

hypertension in humans. 92

The vascular system of rats is particularly

sensitive to angiotens1n93 and can be made more
"vasoexciter material" from humans.

5

SO

by injection of a

Though adrenalectcmy tas been unsuccess

ful in curing renal hypertension in rats and man (contrast dogs) debate

has been heard as to whether all of the adrenal gIani, ....hich is often

mingled lIClth liver tissue in rats, can be removed fran the rat.

94

H~ever,

evidence that the rat hypertension mechanism is similar to tha t of humans
is faUId in t.he formati on in both rats ani humans of antibodies to various

maromalian kidney extrects am the subsequent absence d
by these an tibodies in both mammals.

renin neutralization

87 A modified SKE~39 rat assay

contributes one renin sample activity datln per rat.

The rat, anaes

thetized with sodiun amytal and atropine sulfate, is prepg.red for enzyme
assay by an operation as follews.
table, ventral surface, upward.

from the

a.c:comp~ng

The rat is secured to a dissection

One femoral vein is exposed and seF8ra ted

nerve Sl,nd artery.

The left vagus is exposed and

cut; the trachea is catheterized; the right vagus is exposed and cut;
and the right carotid artery is cleared.

The femoral vein is catherized;

sodilml heparin is injected and washed into the vein "'Ii th Tris-saline;
and the right carotid artery i.s cannulated

a.rn

at.tached to a simple

lIlercury manometer Qy which tbe rat's blood pressure response to femoral
injections of Tris-saline, renin sampl,es, and standard Hypertensin II
may be measured.

A O.2-el sample of renin (pH

7.3 in Tris-saline) or

renin plus inhi m. tor, f olloved by 0.6 ml Tris-saline, is inject 00•
. The change in blood pressure from an averaged baseline is recorded and

a 8uDsequent injection in the same rat of 0.2 ml (0.005 mg) standard
Hypertensin II plus 0.6 m.l Tria-saline is administered.

A Tria-saline

injection equal to the total vol\Jles (0.8 ml) of the renin and standard
Hypertensin II injections precedes the enzyme inj ecti on and indi cates
the vol\De corrections, if any, to be applied to renin and standard pressor
responses.

Renin 'activity (units/ml) of th e injected renin sample is

calculated as follows:

Activity (units

Iml. ,..

Renin-induced elevati on 10.2 ml
X 5

Hypertensin II-induced elevation

The blood pressure elevation is calculated from a threErillinute

baseline (~2 mallcmeter writs) of normal blood pressure which precedes
injection, and is corrected for volume effect.

A maximum range of ,:2.5

mAnOlJleter units 1s permitted betweEn the highest and lcwest baseline.
Throughout the experiment blood pressure is recorded at 15-second in

tervals except

t.m t

the peak for an intel""lal is

elevation falla within t he interval.

~ecorded

if the maximun

To insure' tha. t t he standard does

not have pressor potential beyond the maximum blood treasure limit c£ the

rat,

an injection of excess Hypertensin

n

given at the end of the assay

must cause bloo1 pressure to exceed the resultant blocrl pressure peak of
the standard Hypertensin II injection.

The time required for a. rat

a.S8~

decreases with experience,· hewever

remains exce9Sive considering that only one datum per rat is obtained.

that several renin samples be given to the same rat might be proposed as

25
this would require only one operation, one standard injection, and. one
excess stani ard i njection.out more than one renin sample injected into
the same rat 1II..3iY exhaust the rat I s supply cL renin substrate.

On occasion,

other problems of the assay express themselves in unstable baselines ani
therefore Wltrue blood pressure eleva.tions.

The vagi. are regulator nerves

which signal the heart muscle t<:l countera.ct changes in blced pressure.
When any stram of a vagus is not severed during the operation, threeminute baselines wi thin two manaueter uni. ts nIl nd. be establis hed. and
pressor injec.tions will exhibit blood pressure changes which are altered

by signals from intact strarxls cL the vagi.

WhEn blood or saliva

acc\Dulates. in the tracheal catheter, irregular baselines predominate.
For this reason, the salivary glarrls should be harxlled' delicat.ely.
moot cOIlll1on difficulty en countered in the assay is anaesthesia..

The

The rat IS

bloat pressure will rise frem his baseline without provocation when he
needs additional anaesthetic.

About. ten minutes

l!l1,lS't

elapse after the

anaestheti,c is injected intraperitoneaU.y before a baseline is established.
This baseline will be too 'high wi th insu/! icient a.d'di tiona! anaesthetic
and too l~ with (as llttl,e as 0.05 ml) too much anaesthetic.

Because

the permitted range of the baselines in the assay is only 2.. 5 manometer

units,the amount of anaesthetic judged by the a.ssayer to be necessary
during the assay is critical •.

Data frem rat aS5a~ are averaged and usually yield 15% error or

less.

•
If the error- is mare than 15%, one datum in lour (or any multiple

thereof) may be eliminated by the following statistical treatment.

The
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'three closest data are averafed end their average deviation, and the
a.bsolute <EnsUoo c£ the fourth, from th is average are calculat ed..

The

fourth datlD may be elimimted. statistically if t.he average deviation
of the three retained data is more than four times the deviation of the

fourth datun.

MATERULS

WOOS:

ci~+ and Zn 2 +

-

Indirect Activation c£ Renio

Steer kidneys were defrosted, chopped, then frozen and thawed five
times to break cell lD.8Jlbranes.

One-ml Tris-saline, the homoge1izing

solution, was added per g of wet kidney mince am homogenized at 4 0 in
a Waring blendar.

A portion of this homogenate (Step I)

W83

stored froz.en

for eleven months, at which time th e hanogerEte was thawed, an ali.quot
ftI~,

fer assay removed and frozen and in Step II 400 # homogena~ was centrifuged

in St.ep II at 15 000 rev./min. for 2ft at 4'0.

then

250 ml of supernatant

and an aliquot for assa.y ....ere diluted loli:. th equal. volumes of Tria - 2x

saline.

The aliquot was frozen and the 500 ml diluted supernatant was

dialyzed in Step i l l for three days at 4 0 against six changes of 25(X)

m.l each (five v01unes) of i'ris. (0.05

}of

Tri7.!llA base buffered at pi 7.• 3).

The dialyzed sample from Step TIl was centrifuged and the 5upe~natant was

diluted wi th an equal volume of Tris - 2x saline, and divided: into four
portions

w

an 8O-ml-portion lias added 0.4. m.l H2 0, to a

l~-portion

was a.dded. 1.2-ml. 0.1 M CdC1 2 (1l2.4 p.p.m) and to another l2O-ml L portion

was added 1.2-ml 0.11'4. Zn C12 (65.3 p.p.m.).

The cadmium and zinc

. sample s were O. (X)! H. with re spe ct to their added ca.ti on, as higher
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concentrations r£ zinc caused the s8Jllple to precipitate.'

In Step IV

these three portions were incubated for 44 h at 4 0 ani then centrifuged
at 15 000 rev./min. for 2 h at 4°.

A fourth portion was frozen for

assay, as was an aliquot from each c£ the th ree dialyzed samples fro.m
Step IV.

In Step V a secom dialysis of th e renin sample vas performed.

on each of the Step IV Bupernatants at 4° against five changes of
fifteen volumes Tris-saline; 30 ml of the dialyzed water semple (blank)
supernatant was dialyzed agai ns t a total of

22~

ml Tris-saline'j .30 ml

of the corresponding cadmium sample frozen once was dialyzed against a
total of 2250 ml Tris-$aline j and 60 111.1 of th e 00 ITespondi ng zinc sample

was dialyzed against a total of 4500 ml

Tri~8aline.

An aliquot of the

dialyzed cadmium sample was assayed i.mlDedia tely, and aliq,uots of the
dialyzed. blank and zinc samples were frozen for assBiY.

A third dia.lysis

against Tris-aaline-EDTA (0.001 K EDTA, a chelating agent with high

stability constants for cadlDi\lll and zinc chelates) was done in an effort

to remove cadmitID. and zinc completely from the renin samples.
exception that

TA was used and the volumes used in this (final) Step

VI di.alysis were half thos e
identically performed.
s~ples

With the

0

f Step V, the secaoo and thi rei. dialyses were

Samples frem each of the final dialyzed renin

were frozen for renin assay.

All supernatants and precipitates

except the hcmogena te precipitate, and all dialyZed samples and dialysandB
were analyzed far cadmium and zinc content \d th the at OOlic absorption
spe ctrophotometer.

CalcuJa ti ons fran an ident ical. renin-activation

procedure W'ere used to correct renin activities for volume changes
( Table TI) for purp05 es 0 f ccmpari60n with homo geM te supe rnat.ant a c't.i tit)".
, Results of the Cd2 + and Zn2 + renin activation experiaent are shown in
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320 ml Homogenate

i

centrifugation

ST P II

250 ml Homogenate Supernatant

~

Tr is -sa line
dialysis

STEP III

269 ml Dialyzed Supernatant
Cd 2+-Incubate

lank

120 ml

80 ml
centrifugation

!

7

1

ml

30 ml
Tris-saline
dialysis

120 ml

1

118 ml

117 ml

30

60 ml

1

1

31 ml

1

~
62 ml

!

1

29.5 ml

J

53 ml

1.039

0.997

32 ml
ris-sallneDTA dialysis

n 2+-IncUbate

26.5 ml

ST P IV

STEP V

STEP VI

net volume change:
(Step II - Step VI)
1.010

•

TABLE

II:

V L

.r;

C

ACTIVATIO

DIG A Cd 2+
EXPERIME T

GES
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Kid.ne~rs

ST P I
Kidney Homogenate ( B)
o p.p.m. Cd
4.6 p. .m.

1

P II

Homogenate upernatant D)
0 p.p. • Cd
9.1 p. p.
Zn
1 DD volume
1.31 units/ml activity

1

0

ST PIlI

pernatant CDG)
pop.m o Cd
8 1 p.pom. Zn
1.076
D vol
2.01 Iml activit

Dialyzed

o

0

112.4 po p.m. adde

P IV

• add.ed

T P V

o
o

(

)

Cd
n

n

00997 X
4 30u
0

Legend:
- precipitat
a entheses- C DE
8- supernatant
u- units actvity
R- renin sample
D volume
D- dialysand
- cadmium
zinc
o Cd- 0 po p.m. d
(spectrophotometer
data)

FIGU

VI:

ULTS F TH ' Cd 2 +
P ED '

Zn 2+ HENI

ACTIVATI
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J'igu!'€ VI.

,us

AND METHODS: Extl5.ction of Dialysands for t

Renin Inhibitor

Approximately 2320 III dialysar'li from the ca.d:tJriUII sample dialysis in
Step V of the Cd2

am

Zn2 + renin acti"ation experiment proceaure was

thaWed ana made 0.01 )( with regard to EDT!.

ab olute

he

58U

of 2:1 chloroto

ethanol vas added (25% wlume); the ]ayers were separated atter

stirring 1 h.; and the aqu

0

stored frozen.

Jayer va

ation of the chloroform layer was achieved at

oan t

Partial evapor

perature

d a.tmos

pheric pressure, hCloiever, eva:port~on to apparent dr,yness was aone, at a

. ris - 2:x saline (1.5 al) vas used to

slightly elevated tanperature.
take up the proposed in "bitor.
of the renin

anples were Jrepared

pIe dialyzed by StEp III of the Cd2'6-- Zn2

activation experiment, and 9 ml Tris - 2x saline.
contain

one additional m1 Tris
f

inhibitor . n Tris -2x

aline.

,

and t En assayed"

renin-

The blank sanple

saline and the sample presumed to

inhibitott sample) contained one ml of proposed

conta.1n the inhitibor

40

<x

ch fran 10

'lbe samples were incubated for 22 h at

ediateJ.y.

The blank sanple was expect

identical in every respect to a sampl.e

}7'

to be

eviously assayed. at 2.01 unit.s

activity/ill.

A seoond dialysand, that from the zinc-sample EDTA - dialysis in

Step VI was extracted 'n the same

anner.

A total of 1407

'alysam was made 0.01 M 'th respect to EDT
(25%

olume) of 2:1 chlorofo

and extracted

absolute methanoL

z

c

. th 367.5 ml

After sti lTin

1

, the

31

aqueous layer was

eparated from the chloroform layer a d frozen.

e chloroform layer was evaporated to appare t dry ess at room
temperature a d ope
1 - 2

saIl e.

to the air, a d the

3.

up in

was ta e

ml

The blank prepared was equivale t to a sample

prevlously assayed at 1.3.

its actlvlty/mL

Ibis second'1nhlbltor"

sample was prepared to be J l/J-times as co ce trated in prospect1 e
1

lbltor as the prevlous "1

from the seco d extractio

A th1rd extractl0

ibitor" sample.

were froze

was performed

i cuba ted sample dialyzed i

The layers

a

before assay.

0

the

the Cd 2 +_

ialysa d 0

Step VI agai st KDT.

facilitate dryi g of the extractl0
the extraetl0

The two samples

I

a

effort to

at room temperature a d pressure,

performed with 3:1 aeeto e-etha 01 (25p volume.

ere separated I the orga ic layer was evaporate

pare t dry ess at room conditions; and samples

to ap

ere prepared

re i

sample previously assayed at 3.02'

its/mI.

The "l

re 1

sample was prepared, as in the second e. tractl0"

ith a

lbltor"

to have

.. 1
3 1/3-times the 1nhibitor co ce trat10n of the "1nhlbltor-re
sa pIes of t e

AT RIALS AND

lscrepa cy

lrst extraetio .•

ETH

etween

ta dar

Sta dard Hyperte s1
1

Hyperte s1

I

Batches

prepared from seco d-batch

as assayed

rats a d the blood pressure respo se was compared to t e

respo se f 0

a prev10usly-used sta dard Hypertens1

lrst-batch sta dard

I batch.

as freshly defrosted and compared i

rat w1th seco d-batch sta dards.

the same

e seco d-bateh sta dards were

)2

assayed after havi g bee
o~e

froze

two

ays, froze

day, defrosted two days, a d never froze.

pressure due to volume i jections were

0

e day,

Rises i

ubtracted from

efrosted

bloo
ressor

effec ts.

!'~AT

BIALS

D

~

TH DS

An Attempt to Isolate a Dialyzable Phospholipid Be

teer kid eys were defrosted at 4 0
gro

d tw1ce in a

ho oge 1zed 1

pH 7.)

eat

Step 1 with 1 ml

per g of

trimmed of excess fat,

,

der, frozen a d thawe

r

et mi ce

a

1bitor

1s (0.05

five times, and

Trizma base buffered at

ari g ble dora

I

Step 2 1150 ml

homogeaate was ce trifuged at 15 000 rev.! 1 • a d 6)0 ml supernata t
was recovered.

liquot was diluted by o e-half with

a d frozen for assay.

is-2x saline

(Inltial a says of this sample 1ndioated ex

cessive activity, a d the froze _ sample was further diluted with
an equal volume of

ls-sal

tep 2 was made 0.00)

nata t from

dialyzed for five days aga
volumes)

0

Cd-

e

500

with

7.).

1 homoge ate super
espect to CdC12 a d

as

at five cha ges of 2000 ml each (four

is-saIl e (0.00) - CdC1 2 ,

sali e, buffered at pH
a

e).

o.

5

Trizma base.

o. %

ach day the dlalysa d was placed on

agnetic stirrer with 1 1 of c loroform a d stirred for 24 h.

aqueous layer

as re ove

placed in a bowl
chloroform took
fifth day

a

stored frozen a d the organic layer was

der the hood.
inetee

tep J bega. •

The

Evaporatlo~

of all 5 1 of the

days (approximately) ado,

the twe ty

e residue was scraped from the

sides a d bottom of the vessel w th a deio ized porcelai

spatula
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"and pulverized to a fine powder.

The powder soaked in JO ml 0.05 M Tris

(approx. pIUO) for 1 h, and a cation exchanger (4 g, Carboxy~ethyl

Cellulose, capacity 0.72 meqJg, mediUlll mesh, S!(]ifu\) with 40 m1 Tris was
The supernatant from centrU,ugation (4 0 , 12000 re../min.,

stirred at 40 for 2~ h.

five min.) was collected and brought to a vollBDe of 50 ml with Tria.

The

Jif was adjusted to 7.38 with concentrated HCl and the sample was filtered
by suction through a sintered glass

solution was stored at

4° under a

c~cible.

The resultant "inhibi tor ll

presumed aUftosphere of nitrogen, how

ever as the process for establishing a nit.regen atmosphere involved
mechanical capping of the flask after submission to nitrogen under pressure,

the integrity of the nitrogen at4losphere is questionable.
inhibito.r w.as ext:ractea from 500 III Ibomogenate

A.ssuming all.

st.qJemata~t,

the 50 ml

-inhibitorD solution contains all the inhibitor which was inside the
dia.lysis sacs prior to Cd-Tria-saline dialysis.
was made 0.9% saline with solid Na.Cl.

The uinhibitor" solution

In Step 4 20 ml of ninhibitor ll

was incubated for 25 h wi. th 2 ml homogena tesuperna tant, 2 m1 "'ris - 2x

saline, and 4 ml Trie ..saline.

The incubated sample, cc.mpLred in assay

with activity Qf a sample containing 2 ml hanogenate supernatant; 2 ml
Tria - 2x saline, and 12 ml Tris-saUne, represents a lOO-fold concen
tration of fiinhibitor ll from homogenate supernatant and 8OO·fold concen
tration from the sample cOIlp9.red in assay with the incubated sample.

A

volume correction for renin injections of the renin-inhibitor incubate in
the rat assay aquat ed 0.7 ml inhi bi tor incubate wi th 0.2 ml of the
hcmogenate supernatant diluted 1:4 in Tris-saline.

'l'he corrected total

volume of injections used in the assay of lIinhibi tor" - renin incubate
(only) was

1.3 ml campar

to a usual. tot al. of 0.8 ml.

Activity of the

incubate sample was reported in tems 01' the e:igt:1t-fold dilution of the
homogenate supernatant sBInple.

Cadmium detenninations from spectrophoto

metric analysis showed "Che cadmium context or the inhibitor solution to
be nearly ten times that in the cadmi1.Bl-incubated dialyzed s
Step V f

2+ and. Zn2 + experiJIent suggest

chelating effect

01

8

.01 M EDT! were

an invest.i8ation of' the

'DTA on the ca.......'UUl left in the reniu preparation by

an unsuccessful cation exchange tre tAent in

of

pIe fro

mown

tap 3.

A8 concentrations

to inhibit c nverting enzyme in

ntl'O.

35 a

ple of hcmoge'nate supernatant -.as diluted 1:2 wi th Tris-saline and

canpared 1n assay in Step 5 to an identi cal sample to which EDT._ had been
added to a concentration of O.C02

• Because these EDT! - experiment

samples were diluted to the same degree frOUl the hanogenate as the
renin-i'nhibi tor incu.bate, their assayed aeti vities are ccmparable t.o
ac.tivity, before expression as a dilution of homogenate supernatant. of
the

incubate~

In Step 6. 75 ml of the a,ample dialyzed i.n Step 2

WCUl

dialyzed for five days against five changes 1.125 ml each (15 volumes)

of Tris-saline-ED'fA (O.(X)l M. EDTA) and the resultant sample (71 ml}
retrieved frolD inside the dialysis sacs was decanted and diluted four
fold so that it was assayed i.n Tris-saline.

This diluted sample frem

Step 6 was of the saille order of dilution from the homogenate 'Supernatant
(four-fold) as the Cd-Tris-saline-dialyzed sample diluted from Step 2.

This inhibitor isolation eXperiment indicated that, when corrected by
dilution and other volU!lle change calculations, to expected activities of
Wldiluted samples. the diluted samples showed markedly higher aetiviti
than the assayed activities of undiluted preparations.

Figure VII

shows the resul ts of the renin inhi hi tor isolati. on experiment.
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Kidneys

STEP 1

!

Kidney Homogenate (FA)

TP2!

21

1:2

Homogenate
upernatant (FB)

1:2

~(

( FC )

t ) _ _-""'I~~

5.07

un1ts/ml

1 :4
(FK) .....~......_-D1alyzed

2.33

upernatant (FD)

+ Aqueous Dialysand

units/ml

+
T

3

(F~)

rgan1c Dlalysand

FF)

1

"Inhibitor"
4

"Inh1bitor" enin
Incubate (
)
1.20
units/ml

1: 2

S r 'P

(FI)
4.30

units/ml
!!;p

5

1:2

(~DTA)

(FJ)
4.46
units/ml

6

(FL)~4~----Tris-saline-D

5.51?

renin sample(

A-diaAyzed
)

•

units/ 1

FIGU

VII:

ULTS

F TH

I

IBI

R IS LA

EXPER

E-T

( atias indicate order of dilution 1n Tr1s-saline or
Tris-saline- D A)
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o .KE1J:IODS t

Investigation of Pre-Slaughter Steer Diets for High Cd 2 + and Zn2 +- Content

The renin samples fran the inhibitor isolation experiment had high

activities and were prepared from kidneys of steers slaughtered in
January.

Previo\lsly-assayed renin samples prepared fram steers slaughtered

in July and in June had le~s renin activity.

A.!c'o Packing Company and

the local Agway feed store were consulted as to possible seasonal variations
of pre-slaughter s,teer diets which might introduce varying le'Yels of
Cd 2 + and Zn 2 + i'nt.c the steer.

•
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DI CU 81

d 2 + and

n 2 +__

ndirect Activation of _enin

No loss of renin e.ctlvi ty from the frozen homogenate

was found:

the renin e.c ti vi ty of the hO:i1ogenate super atant

was cOlf:parable to the activi ty of an identically-tr.eated sample
The first dialysis (against

assaJed. eleven months earlier.
Tris in Step

II) enhanced renin activity about one-and-a

half times from the homogenate supernatant activity.
loss by dialysis of a renin depressor is implied.
gain in sample volume fro

e

A small

homogenate supernatant volume was

experienced with dialysis.

Incubation with cations in

further increased renin activity.

The blank sample was

slightly activated, apparently by scant dilution.
phenomenon is not understood.

tep

This

One-fourth of the added-Cd 2+

and one-half of the added-Zn 2 + precipitated during cation

inc~bation.

Added-Cd 2+ activated the renin preparation to a

greater extent than did added-Zn 2 +.

After completion of dialysis

by Tris-saline in Step V, more than eO% of each a
had been precipitated or dialyze

ed cation

from the renin samples.

enin activities for all the samples reached their maxlmwns±,5.5%
after this step, indicating further activation of renin by the
removal of the cations.

The final dialysis (against Tris-saline

EDTA) removed only about 15% more cation and
ties dld not show further activation.

generall~

actiVi

In fact, e. slight de

crease in activation was displayeu by the blank and the Cd 2 +-
incubated sample.

Some deterioration of the enzyme preparation

38

1s suspected.

~fuile

the blank and cadmium samples dialyzed in

Step VI lost activity, the zinc sa pIe gained

5%

activity.

The

zinc saDple is the only final fraction which lost net volume
from the hO:logenate supernatant.
renin activity and dilution of

A correlation between gain in

re~ln sa~ple

is possible.

Dialyses of cation-incubated renin preparations increased
the activities of renin samples approximately three-fold over
the activity of the homogenate supernatant.
activity increased approximately two-fold.

The blank sample
(Again, the blank

activity-increase phenomenon 1s not understood).

For t e final

fractions, net volume changes occurring with precipitations and
dialyses averaged I.Ols-times the homogenate supernatant volume.

97.1% of the added 65.3 p.p.rn. Zn 2 + were recovered from precipi
tates and dialysands.
showe~

In this experiment both Cd 2+ and 2n 2+

indirect activation abilities toward

re~ini

ho~ever

the

overall Cd 2 +-activation of the renin preparation exceeded by

15%

that of the overall

n 2 +-activatlon.

The presence of 2n 2 +

in the kidney homogenate (and the absence of Cd

2

1 concun with

expectations that 2n 2 +, and not Cd 2 +, is an essential trace
metal in the ~idney.70,78 Because a small amount of Zn 2 + is
endogenous, the presence of additional Zn 2+ in the kidney ma~
be expected to have a lesser effect than would additional Cd 2+,
a toxic, cumulative 79 trace metal.

Another possible explanation

for the lesser renin activation by Zn 2 + may lie in the incuba
tion-step precipitation of twice as much (%) of the added Zn 2+
as the added ~d2+.

A zinc-chelate having a higher stability

39
constant for Cd 2+ than Zn 2+ will replace Cd 2+ in a renin
activating role.

Perhaps ~CHRO~DERIS77 observation of a

"reversal" of Cd 2 +-induced hypertension by such a zinc-che
late may be more correctly interpreted as a less intense
activation of renin by Zn 2 +.

A revised scheme of suspected

phenomena of the renin-angiotensin system as elucidated by the
Cd 2 + and Zn 2+ renin-activation experiment is shown in

ESULT

AND DISCU

igure VI I.

ION:

Extraction of Dialysands for Renin Inhibitor

The cadmium-sample _ is-saline dialysand (from Step' of
the Cd 2+ and Zn 2+ renin-activation experiment) theoretically
should be the dialysand containing the highest concentration of
renin inhibitor.

e activity of the renin sample dialyzed to

produce this dialysand had the highest renin activity in the
Cd 2+ and Zn 2+ renin-activation experiment, indicating, at this
step, the most complete loss of the inhibitor.

For this reason

the first dialysand extraction was performed on the cadmium
sample 'ITis-saline dialysand.

The "inhibltor"- renin sample

and the control-renin sample from the first dia1ysand extraction
were assayed and found to have ac ti vi ties of 1-.98 uni ts/m1 and
230 units/ml respectively.

The latter activity exceeds by 15%

the activity shown by previous assay of the sample

(~.Ol

units/mI.)

A decrease caused by additlon of the proposed inhibitor is not
conclusively attributable to the presence of a renin inhibitor.
If the inhibitor was indeed present, activity

wo~ld

be expected
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to disappear, or certainly to decrease markedly.

The decrease

in activity shown may reflect any interfering characteristics
of the proposed inhibitor solution toward renin activity.
use of heat to complete the evaporation of the

The

chlo~oform

IDay

have altered the structure of a possible phospholipid inhibitor.

e samples of "lnhibitor"-renin and control-renin pre
pared in the second dialysand experiment were incompletely as
sayed.

Preliminary assays reported the inhibitor-renin sample

to have an activity 1n excess of the activity previously assayed
for the control-renin sample.

The control-renin sample assays

reflected a loss of nearly one-half the actiVity as previously
assayed.
galne

Because the activity of the Zn 2 +-incubated sample

(5%)

activit'y during EDTA dialysis, the dialysand of

this dialysis was suspected to contain a small amount of renin
inhibitor.

However, this gain in activity, as previously men

tioned, may be due to dilution of the Zn 2 +-inCUbated sample,
and actually no inhibitor may be present in the dialysand ex
tracted 1n this second experiment.

"Inhlbitor"-renin and control-renin samples from the third
dlalysand extraction experiment were assayed and found to have
activities of

2.64

units/ml and

3.30

units/ml, respe~tively.

As in the first dial,ysand e::traction experiment, the "1nhi bi tor"
renin sample showed only a slight decrease in activity.

Because

the Cd 2 +-1ncubated sample did not gain activity (and in fact lost

activity} in the Step VI-iIDTA dialysis,

the "inhibitor"

renin sample was not suspected to illustrate an inhibitorinduced loss of activity in this extraction experiment.

e

slight decrease in renin activity of the "inhibitor"-renin
sample in the first extraction experiment may be interpreted
to be independent of inhibitor effect, but the difference of
organic solvents used should be noted o

Results of dialysand extraction indicated that a renin
inhibi~or

was not effectively extracted from aqueous solutions.

Conclusive evidence for the presence of a renin inhibitor in
any of the

d~lysand

As reported by

extractions was not found.

.

b

EBY, and B !PUS,9 0 the renin inhi

bitor is suspected to be a phospholipid
phatidylserlne.
tldylserlnes.

s~ilar

to bovine phos

Phosphoglyceride phospholipids include phospha
The general structure and reactions of phospha

tldylserines are given in Figure IX with the structure proposed
by S

t

and

:p

90

for the renin inhibitor.

e struc

ture of the inhibitor is integral for inhibitory activity.

Re

moval of one of the fatty acids from the inhibitor is necessary
for conversion from the inactive precursory
the inhibitor to the active inhibitor.

i~~ibitor

form of

Snake venomPhospholi

pase A performs this beta-cleavage to a lysophosphatide in Vitro •
•
Inhibitory activity is destroyed by removal of both fatty acids,
of the

phospho~~l~e

3rouP, or of the amino acid.

~xposure

of

the inhibitor in the dialysand extraction experiments to water

4)

"Phosphotl'p'lcls: je.t1entl tJtrurl",...~
o

II

Hz..c. - '" -c ,
S
Ii

Xl

c- 0 -c.-1lz.

I
~
Hl.C-O-P- 0- CH
I

J

ON

~3

-~H- COdH

I
f{~

o

II

HIt - 0- Co -'ttl
I

~

I

~I

He -0-<: - ~1
H,C- 0- 'P-o "

I

oH

c.w - tH
I
I

~3

KWz.

-

tOOH

an~_

~i:!"

.""'y have oxidized the inhibitor precursor molecule to

a form from which activity could not be derived.

One end of the

phosphatidylserine molecule is hydrophilic; the other is hydro
phobic.

xtraction from an aqueous dialysand with a solvent.

non-aqueous, organic solution is expected to be successful.

'The

solubilities of phosphatldylserlnes differ and are determined;
by x-group amino acids and amino acid side chains.
phatldylserine amino acid is serine, an

The phos

hydr~r-amino

acid: how

ever, the side chain of the phosphatidylserine-like renin inhi
bitor is unkno\'ln.

That the renin inhibitor is soluble in ace

tone, petroleum ether. 2:1 and 4:1 chloroform. methanol, ethyl
acetate, and ethyl ether may be deduced from the
and Bmp s9 0 paper.
in alcohol.

-~

BY,

Phosphatidylserines are usually insoluble

owledge of the negative charge on the polar group

(serine) and the unsa tura ted fatty ac id in the non-polar x'eglon
of phosphatidylserlnes may further facilitate understanding of
the possible effects of renin inhibitor extraction techniques.

RESULTS AND DISCUSSIO :
Discrepancy Between Standard Hypertensin II Batches

Acc

-~ing

to pressor response in bioassay, the first-batch

standard Hypertensin II was found to have only two-thirds the
activity of the second-batch standard.

A renin sample assayed

using the first-batch standard Hypertensin II for calculation
of renin activity wu-- expected to display 50% higher activity

45

than a sample assayed using the second-batch standard.

Renin

samples assayed, using second-batch standard, in the inhibitorisolation experiment following this standards experiment. were
expected to display two-thirds the renin activity normallv
shown by similarly-treated and previously-assayed (using firstbatch standard) samples.

Trte second-batch standard ffiaintained

activity through freezing and defrosting; however, a loss of
activity was observed in samples which had been defrosted for
more than two days.

In the subsequent experiment second-batch

standards were stored frozen until use and were not used after
having stood defrosted for more than two days.

M

DI

eu

SIGN:

An Attempt to Isolate a Dialyzable Phospholipid Renin Inhibitor

The inhibitor-removing action of simultaneous dialysis and
cation-incubation on renin in the Cd-Tris-saline dialysis in
Step II (see F gure VII)

shoul~

theoretically, remove a

~axi-

urn amount of a ranin inhibitor from the dialyzed sample.

Ex

traction of the dialysand with an organic substance, in which
a phosphatidylserine-like renin inhibitor is believed to be sol
uble, should result in the isolation of such an inhibitor.

In

cubation of a dilution of the kidney homogenate supernatant with
•
an inhibitor~ containing aliquot, should depress homogenate super
natant markedly or completely.
Although second-batch Hypertensin II was used to calibrate
renin activity in this experiment, the activity of the diluted

6

homogenate supernatant before dialysis was in excess of, and
not d1minlshed (as expected) from, the activity of a similarlytreated and preViously-assayed dilution of homogenate superna
tanto

Further dilution of the diluted homogenate supernatant

with an equal volume of Tris-saline (net four-fold dilution)
failed to decrease activity significantly (1.6% decrease).
CdCI2' 0.003

~t

in the presence of renin and Tris-saline caused

a small amount of precipitate to be formed inside the dialysis
sacs during dialysis.

Th

assa~e~

pIe from Step 2.

activity of the dialyzed renin sam
from a four-fold dilution and corrected

to undiluted sample activity. was approximately three-times the
activity shown by a preliminary undiluted, dialyzed sample.
CdC12' 0.001

1,

0.002 N. and 0.003 ¥I, injected with Tris-saline

intravenously in the rat caused immediate and marked depression
of blood pressure (8-16 units) followed by eventual (about seven

m~~utes)

resumption of baseline pressure (contrast Maier, et al.

86

This Cd2+ phenomenon suggests that the activity of the diluted,
dialyzed sample from Step 2 mav have been depressed by the pre
sence of CdC1 2 during assay.

Consequently, the activities of

diluted and dialyzed samples may have been comparable in the
a~sence

of CdC1 2 "

In Step

no effect on the assayed
of the homogenate

5,

EDTA.

~crin

supern~tant.

0.002~.

was found to have

activity of an eight-fold dilution
The activities of the four-fold

dilution and this eight-fold dilution of homogenate
were comparable, + 15%.

s~pernatant

However, the eight-fol~ ~11ution which

had been incubated with "inhibitor" solution showed an activity
of only one-third that shown by the control (eight-fold

homogen~te

).
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supernatant dilution) and the EDTA-inoubated, eight-fold di
lution samples.

Evidenoe for the presence of a renin inhibitor

was again not conslusive, although the activity of the "inhibitor"
renin incubate was depressed to a greater extent in this experl
ment, when equivalent (all eight-fold) dilutions were compared,
than in the previous inhibitor extraction experiments.

In this

experiment, only chloroform ,'ras used to extract an "inhibitor"
from the dlalysand of Cd-'ITis-saline dialysis in step 2.

Pre

vious uses of organic and polar solvent mixtures for extraction
of aqueous dialysands may have failed due to the presence of ex
cess aqueous solvents.

The "inhibitor"-renin incubate was found to be high in Cd 2•
(approximately 0.002 M) and, according to the Cd 2+-phenomenon
investigated above, high Cd 2+ content may have been responsible
for the renin activi t~," n.epression observed in the Itinhlbltor"
renin incubate. ..lliether a Cd 2+ -free "inhibitor"solution will
depress the renin activity of an eight-fold dilution of the homo
genate supernatant remains to be investigated.

Renin activities assayed in four-fold dilutions of the
samples dialyzed in Steps 2 aRd 6 were compared.
by

Removal of Cd 2+

TA-dialysis in Step 6 increased assayed renin activity by

more than two-fold.

According to this data, the addition of a

Cd 2+-rich "inhibitor"-solution to a dilu:t1on of Cd 2+-free homo
genate supernatant may have been responsible for much, if not

8

all, of the depression of assayed renin activity shown in
Step

5.
If the "inhibitor

ll

solution does not contain a renin inhl

bitor, a possible error in inhibitor extraction lies in exposure
to the air of the dried chloroform-extract from the Cd-Tris-sa
line dlalysand.

As mentioned above, oXidation of the proposed

phosphatidylserine-llke inhibitor structure can result in loss
of activity.

Because the spacial configuration of renin in un

known as yet, inhibitor oXidation possibilities cannot be dis
cussed thoroughly.
Cd-Tris-saline

Another possibility of error lies in the

dlal~sand.

An inhibitor was expected to be in

this dialysand because from the previous Cd 2+ and Zn 2 + renin
activation experiment, Cd 2+-renin dialysis resulted in continued
elevation of renin activity.

For this reason, a dialyzable in

hibltor-Cd 2+ complex was believed to exist.

If

this complex,

as in the inhibitor isolation experiment, was dialyzeQ ~~inst
Cd 2+-Tris-saline, the lnhibitor-Cd 2+ complex would have been
expected to leave

t-.\'l~

re>'liYl

sa.~:ple

ent·er the (Ual'Tsa",d wh~ le c:c 2+
by entering the dialysis sacs.
activity shown by the

in

+\."1"

dialys1s sacs al1d

11.1(1 ha",re re 1 ce r

the comnl x

The apparent increase in renin

TA-dialyzed sample (dilution) over the

Cd-Tris-saline dialyzed sample (dilution) may have been due to
the d~pression of rat ~l~od pressure by the presence

of

Cd 2+ in

the latter sample, and not to a loss of a renin inhibitor.

How

ever. if a renin inhibitor were dialyzed from the renin sample

49
by ED A-dialysis, extraction of the previous (Cd-Tris-saline)
dlalysand would have been fruitless.

A third reason that the

inhibitor failed to be demonstrated in the2inhibltor~renin in
cubate may be that because the initial (homogenate

~upernatant)

activity was abnormally high, the steer kidney used in this pre
paration contained little or no

i~J!ibitor.

Because the activities of diluted and undiluted renin sam
pIes were found to be comparable in this experiment, the volume
n 2+ renin activa

correction calculations used in the Cd 2+ and
tion experiment (and Maier, et al.

--

86 ) may have been invalid.

Care must be taken to compare samples of equivalent dilution
from the homogenate supernatant to avoid this suspected dilution
The zinc-incubated sample in the Cd 2+ and ~n2+ renin

error.

activation experiment was the only sample experiencing dilution

(a.997

x volume of

dialysis.

ho~ogenate

supernatant) in the final (ROT

_ e linear volume correction leadi

to c o=-~"'ec ted

renin activity of the Binc sample would have led to a slightly
higher activity than eXisted.

~ne

zinc sample was also the only

~DTA-dialyzed

sample reported to have gained activity

correspondin

TTls-saline-dlalyzed sample.

rectlonmlculations may be responsible.

fro~

the

Invalid volume cor

~e~1n

activities of

various dilutions of a renin sample are currently being compared
•
in bioassay in an attempt to determine the valid volume corrections.

R

ULTS

m

I CU

ION:

Investigation of Pre-Slaughter Steer Diets for High Cd 2+ and
Contents

n

2+
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a~king

Alco

Company receives only about eighty steers

for slaughter per year.
comes from dairy cattle.

lost of the beef distributed by Alco
Only the steers are raised for beef

on a semi-standard program.

The steer program recommended by

Agway is not used universally and to trace the steer from which
the kidney renin preparations were made would not be possible.
Therefore, the following information on steer diets can be used
.
2+
2+
only for an indication of dletary-Cd
and -Zn
effects on the

kidneys treated in our laboratorv

•

Depending on the age of the steer. a fattening program
including extra protein is used in pre-slaughter diets for two
to six months.

In this program the bulk of the steer diet con

sists of grain feeds, 'J5% Beef Nix" and "J
gardless of the season. (55~

Beef Eix-ND,

II

re

eef Mix contains grains and hor

mone diethylstilbestrol, and 32% Beef

r· ix-!

I

(non-drug) 1s used

for extra protein when the daily limit of hormone has been eaten).
Another grain feed, "32'% Beef Ivlix" (containing hormone)
used in approximately double quantities in place of

55%

t

may be

Beef Nix.

The remainder of the steer diet consists of hay (free choice or
limited), corn silage (free choice), and high moisture corn (free
choice).

Beginning in .ay, pasture grass or legume roughage is

available, and a steer slaughtered in
had two
diet.

o~

JQ~e

or in July will have

three months of pasture-grass contributing to his

However, the bulk of his pre-slaughter diet remains a

Beef iljix

rain.
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t)
Wheat Bran

32% -

D

0.88

32

-

D

0.83-0.86

Corn gluten

32
55

-ND

0.46-0.57

Alfalfa

55

Dried grai s

32,% 55

Cane molasses

55~

winter l e t

99.4-100.4

5.7-29.6
ND

0.3-0.49

winter rye

TAB

I

C

according to

45-52

0-51.4
35-43.6

·r
CHR

DIe C
DEB, ~ al 7~

I

•

11!iS
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Examination of the declared contents of a typical pasture
LUl'~ber

seed (Fora.ge M:ixture

1-2) s old by Agway revealed no in

formation about Cd 2+ or Zn 2+ contents.

The

55%

Beef Mix was

=n

advertised to contain five substances suspected by SC

et a1. 74 to be high in Cd 2+ (more than 0 • .5 mg/g dry weight) or
Zn 2+ (more thal1 ~·5 mg/g dry weight).

The

32.;; Beef

ix-ND con

tains one additional substance which is believed to be hi h in
both Cd 2+ and Zn 2+.

Table III shows this data.

As previously

stated, these data cannot giV2 conclusive evidence as to dietary
effects of seasonally ~~rying Cd 2+ and Zn 2+ effects.
seasonal

No such

var~ation is observable, however, but a high winter Cd 2+

or Zn 2+ diet has not been disproved in such special cases as the
steer from which the January

ki~Dey

preparation was made.

By the standards given above for high Cd 2+ and ~n2+ con

tent per g dry weight, the Purina Laboratorv

Cho~';,

used by our

laboratory to feed the assay rats, is high in both Cd 2+ (0.63 mg/g
dry weight) and ~n2+

(58.1 gig

quantities eaten per day

Dj7

(~y weight).

However, the

a rat are so small that a rat must

eat four-to-flve-times his body weight in Laboratory Chow to
induce hypertension, according to calculations based on
S
0 • .5

ROED

mimI

' S 73 Cd 2+-induced hypertension experiment in which
drinkln

ater was SUfficient to induce hypertension •
•

Crude renin preparations from steer kidneys were incubated

53
with Cd 2+ and with Zn 2 +.
in both prepar tions.

levation of renin activity resulted
ialyses of each preparation against

Tris-saline, and finally EDTA , removed the cations; however,
renin activity remained elevated.

An indirect activation of

renin by Cd 2+ and, to a lesser extent, Zn 2+, was thus demon
strated.

Removal of the cations by Tris-saline and

DTA-dialyses was

suspected to involve the loss by dialysis of a renin inhibitor.
An isolation technique for a proposed phospholipid renin inhi

bitor similar to

bovi~e

phosphatidylserlne, reported by an

other laboratory,9 0 -9 1 was thought to be unnecessarily arduous
due to the probable location of an inhibitor in the 'lTls-saline
Bnd EDTA-dialysands (the sample outside the dialysis sacs) of
Cd 2 + and Zn 2 +-incubated renin samples.

t~actions of

is-saline-and ED 'A-dialysands of Cd 2+- and

Zn 2+-incubated renin samples for a phospholipid renin inhibitor
were attempted uslng various m1.xtures of organic and polar 801
vents.

Renin samples incubated with reconstituted "inhibitor"

extractions did not demonstrate marked or total activity depres

s lone

e dialysand of an highly active kidney homogenate

super~

•

natant dialyzed against Cd-Tris-saline was extracted witb chloro
form and evaporated.

'!he proposed "inhibitor" residue

~'IPS

constituted, treated, and incu'bated with a renin sample.

re
i>j-arked

depression of renin activity resultedJ however, this may have
been due either to a high Cd 2+-content or to the presence of an
active renin inhibitor.

Dilution of renin samples and the assayed resultant ac
tivities were not linear according to initial observations.
Data of earlier experiments had been interpreted using a linear
dilution-volume rela t1.onship and, pendi113 further imTes tiga tlon
of a possible non-linear relationship, will be held in abeyance.

Pre-sla

~hter

steer diets were examined for, but failed

to show a winter increase in Cd 2 +- or Zn 2 + content.

Such a

phenomenon would have explained the uniquely high activity of
the January steer kidney renin preparation in
duced renal hypertension.

ter~s

of diet-in

Little or no inhibitor would be ex

pected in such a kidney preparation.

-'~a j, or

areas l'lh ich have not be en inve s t iga ted are, firs t

I

extraction of the EDTA-TTis-saline dlalysand for a phospholipid
renin inhibitor, and second, incubation of a (Cd 2 +-free) renin
sample with a Cd 2+-free "inhibitor" solution extracted in the
manner described in the

ir~ibitor

isolation experiment reported

here.
•
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